GENOM BIO

News | Leaders from Guoyuan Securities and Lixin Urban Investment Group visited GENOM BIO

2023-04-07 17:59 Source: admin Clicks: 48

cb8c31098ec3087dfd2bb8bf3fe183ee_2-23040G31455393.jpg


On April 5-6, 2023, Shi Wenge, Investment Director and General Manager of Fund One of Guoyuan Equity Investment Co., Ltd., Qian Cheng, Investment Manager of Fund One, Liu Fuxiu, Party Secretary and Chairman of Lixin County Urban and Rural Development and Construction Investment Group Co., Ltd., Liu Wenlong, Manager of the Group's Financing Department, Li Jipeng and other leaders visited GENOM BIO for inspection and guidance. Dr. Li Liang, Chairman and CEO of Zhejiang GENOM Life Science Holding Group, Wang Xichen and Guo Yonglin, Vice Presidents of the Group, Dr. Zhuang Lenan, Chief Scientist of the Group, Dr. Ren Daxi, and Dr. Li Tang, General Manager of the Group's Big Health Business Unit, and other company leaders accompanied the inspection.


1f63f96b33589afce218503f2e4dae2b_2-23040G31622511.jpg


Accompanied by Dr. Li Liang, Chairman and CEO of the Group, the leaders visited the headquarters of GENOM BIO, the joint laboratory of Zhejiang University and GENOM BIO at the Zijingang Campus of Zhejiang University, the central laboratory of Zhejiang Provincial People's Hospital, and the GMP clean workshop factory of GENOM BIO Haining for production and research and development.


fac01fa7ea3b893e875ec53f6a424c13_2-23040G31G4446.JPG


At the symposium, Dr. Li Liang introduced in detail the company's development prospects and product advantages, its highly competitive product system, and its all-round technical service system. The leaders had a deeper understanding of GENOM BIO's product and service system, and fully affirmed GENOM BIO's current layout and future development plan, laying a solid foundation for the next step of promoting the strategic investment of Guoyuan and Lixin Urban Investment Group in GENOM BIO. Both parties expressed their willingness to promote the subsequent equity investment work as soon as possible, and fully assist the healthy development of GENOM BIO in terms of financial support, industrial resource introduction, etc.